AI Medical Service’s ‘gastroAI-model G’ software analyzes endoscopic images in real-time. It has the capability to classify lesions as neoplastic (potentially cancerous) or non-neoplastic with immediate visual feedback, confidence levels, and lesion localization.
This innovation addresses critical challenges in gastric cancer detection, where early-stage diagnosis dramatically improves survival rates but remains difficult to diagnose in clinical practice due to subtle visual cues. The approval holds particular relevance for Thailand’s healthcare landscape, where late-stage detection contributes to a 75% mortality rate amid demographic shifts toward an aging population and anticipated shortages in specialist care.
Image Credit: AI Medical Service
